Comprehensive Overview of Non-Clinical Studies in Drug Development

Comprehensive Overview of Non-Clinical Studies in Drug Development

• 2.
  Learning Objectives After thislecture students should be able to ✓ Explain the importance of non-clinical studies ✓ Describe different pharmacology studies ✓ Understand ADME evaluation ✓ Explain major toxicology studies ✓ Understand Good Laboratory Practice (GLP) ✓ Explain regulatory expectations before IND submission
• 4.
  Objectives of Non-ClinicalStudies The major objectives are Demonstrate efficacy Does the drug produce the desired biological effect? Evaluate safety Identify possible adverse effects. Determine dose Estimate safe starting dose for first-in-human studies. Understand pharmacokinetics How the drug behaves inside the body. Support IND application Provide evidence that human exposure is reasonably safe.
• 5.
  Why Are Non-ClinicalStudies Important? They help answer ✔ Does the drug work? ✔ Is it safe? ✔ Which organs are affected? ✔ What dose should be tested? ✔ Can the study proceed to humans? Without adequate non-clinical evidence, regulatory agencies will not permit clinical trials.
• 24.
  Summary ✓ Non-clinical studiesbridge drug discovery and human clinical trials. ✓ They establish proof of concept, characterize pharmacology, and identify potential safety risks. ✓ ADME studies define how the drug is absorbed, distributed, metabolized, and eliminated. ✓ Toxicology studies determine target-organ toxicity and support safe dose selection. ✓ GLP ensures the quality, integrity, and reliability of non-clinical data. ✓ A comprehensive non-clinical package is essential for regulatory review and successful IND submission.